Vα14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes

Hirofumi Ohtaki, Hiroyasu Ito, Kazuki Ando, Tetsuya Ishikawa, Kuniaki Saito, Michio Imawari, Takashi Yokochi, Hisataka Moriwaki, Mitsuru Seishima

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Vα14 natural killer T (Vα14 NKT) cells activated by α-galactosylceramide (α-GalCer) secrete a large amount of Th1 and Th2 cytokines. IFN-γ plays a crucial role in the inflammation response, and is also known as an activator of nitric oxide (NO) production. We previously reported that lipopolysaccharide (LPS)-induced NO production is augmented by α-GalCer in mouse peritoneal cells. Since the liver is susceptible to LPS stimulation via the portal vein, we examined the effect of α-GalCer on LPS-induced NO production in murine intra-hepatic lymphocytes (IHLs). Although IHLs augmented LPS-induced NO production by α-GalCer administration, such an augmentation was not observed in non-treated mice. Furthermore, α-GalCer did not augment LPS-induced NO production in IHLs from IFN-γ knockout mice. In flow cytometry analysis of IHLs from α-GalCer-treated mice, the ratio and number of F4/80- and TLR4-positive cells rose as compared with non-treated mice. The liver injury may be induced by LPS and NO under the condition where Vα14 NKT cells were activated.

Original languageEnglish
Pages (from-to)579-583
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume378
Issue number3
DOIs
Publication statusPublished - 16-01-2009
Externally publishedYes

Fingerprint

Natural Killer T-Cells
T-cells
Lymphocytes
Lipopolysaccharides
Nitric Oxide
Liver
Galactosylceramides
Flow cytometry
Portal Vein
Knockout Mice
alpha-galactosylceramide
Flow Cytometry
Cells
Cytokines
Inflammation
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Ohtaki, Hirofumi ; Ito, Hiroyasu ; Ando, Kazuki ; Ishikawa, Tetsuya ; Saito, Kuniaki ; Imawari, Michio ; Yokochi, Takashi ; Moriwaki, Hisataka ; Seishima, Mitsuru. / Vα14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes. In: Biochemical and Biophysical Research Communications. 2009 ; Vol. 378, No. 3. pp. 579-583.
@article{1f790f10e5704bd0a93cfad50de0d8ad,
title = "Vα14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes",
abstract = "Vα14 natural killer T (Vα14 NKT) cells activated by α-galactosylceramide (α-GalCer) secrete a large amount of Th1 and Th2 cytokines. IFN-γ plays a crucial role in the inflammation response, and is also known as an activator of nitric oxide (NO) production. We previously reported that lipopolysaccharide (LPS)-induced NO production is augmented by α-GalCer in mouse peritoneal cells. Since the liver is susceptible to LPS stimulation via the portal vein, we examined the effect of α-GalCer on LPS-induced NO production in murine intra-hepatic lymphocytes (IHLs). Although IHLs augmented LPS-induced NO production by α-GalCer administration, such an augmentation was not observed in non-treated mice. Furthermore, α-GalCer did not augment LPS-induced NO production in IHLs from IFN-γ knockout mice. In flow cytometry analysis of IHLs from α-GalCer-treated mice, the ratio and number of F4/80- and TLR4-positive cells rose as compared with non-treated mice. The liver injury may be induced by LPS and NO under the condition where Vα14 NKT cells were activated.",
author = "Hirofumi Ohtaki and Hiroyasu Ito and Kazuki Ando and Tetsuya Ishikawa and Kuniaki Saito and Michio Imawari and Takashi Yokochi and Hisataka Moriwaki and Mitsuru Seishima",
year = "2009",
month = "1",
day = "16",
doi = "10.1016/j.bbrc.2008.11.075",
language = "English",
volume = "378",
pages = "579--583",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

Vα14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes. / Ohtaki, Hirofumi; Ito, Hiroyasu; Ando, Kazuki; Ishikawa, Tetsuya; Saito, Kuniaki; Imawari, Michio; Yokochi, Takashi; Moriwaki, Hisataka; Seishima, Mitsuru.

In: Biochemical and Biophysical Research Communications, Vol. 378, No. 3, 16.01.2009, p. 579-583.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vα14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes

AU - Ohtaki, Hirofumi

AU - Ito, Hiroyasu

AU - Ando, Kazuki

AU - Ishikawa, Tetsuya

AU - Saito, Kuniaki

AU - Imawari, Michio

AU - Yokochi, Takashi

AU - Moriwaki, Hisataka

AU - Seishima, Mitsuru

PY - 2009/1/16

Y1 - 2009/1/16

N2 - Vα14 natural killer T (Vα14 NKT) cells activated by α-galactosylceramide (α-GalCer) secrete a large amount of Th1 and Th2 cytokines. IFN-γ plays a crucial role in the inflammation response, and is also known as an activator of nitric oxide (NO) production. We previously reported that lipopolysaccharide (LPS)-induced NO production is augmented by α-GalCer in mouse peritoneal cells. Since the liver is susceptible to LPS stimulation via the portal vein, we examined the effect of α-GalCer on LPS-induced NO production in murine intra-hepatic lymphocytes (IHLs). Although IHLs augmented LPS-induced NO production by α-GalCer administration, such an augmentation was not observed in non-treated mice. Furthermore, α-GalCer did not augment LPS-induced NO production in IHLs from IFN-γ knockout mice. In flow cytometry analysis of IHLs from α-GalCer-treated mice, the ratio and number of F4/80- and TLR4-positive cells rose as compared with non-treated mice. The liver injury may be induced by LPS and NO under the condition where Vα14 NKT cells were activated.

AB - Vα14 natural killer T (Vα14 NKT) cells activated by α-galactosylceramide (α-GalCer) secrete a large amount of Th1 and Th2 cytokines. IFN-γ plays a crucial role in the inflammation response, and is also known as an activator of nitric oxide (NO) production. We previously reported that lipopolysaccharide (LPS)-induced NO production is augmented by α-GalCer in mouse peritoneal cells. Since the liver is susceptible to LPS stimulation via the portal vein, we examined the effect of α-GalCer on LPS-induced NO production in murine intra-hepatic lymphocytes (IHLs). Although IHLs augmented LPS-induced NO production by α-GalCer administration, such an augmentation was not observed in non-treated mice. Furthermore, α-GalCer did not augment LPS-induced NO production in IHLs from IFN-γ knockout mice. In flow cytometry analysis of IHLs from α-GalCer-treated mice, the ratio and number of F4/80- and TLR4-positive cells rose as compared with non-treated mice. The liver injury may be induced by LPS and NO under the condition where Vα14 NKT cells were activated.

UR - http://www.scopus.com/inward/record.url?scp=57749174056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57749174056&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.11.075

DO - 10.1016/j.bbrc.2008.11.075

M3 - Article

C2 - 19056341

AN - SCOPUS:57749174056

VL - 378

SP - 579

EP - 583

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -